Detection of membrane-bound tumor necrosis factor (TNF): An analysis of TNF-specific reagents

Microscopy Research and Technique

Volumn 50, Issue 3, 2000, Pages 243-250

  Gerspach, Jeannette ^a   Götz, Alex ^a   Zimmermann, Gudrun ^a   Kolle, Carmen ^a   Böttinger, Heiner ^a   Grell, Matthias ^a,b  

^a UNIVERSITY OF STUTTGART   (Germany)

^b MERCK KGAA   (Germany)

Author keywords

Flow cytometry; Reagents; TNF receptor fusion proteins

Indexed keywords

GLYCOPROTEINS; MACROPHAGES; MAMMALS; RECOMBINANT PROTEINS; TUMORS;

BIOACTIVES; CYTOKINES; FUSION PROTEINS; HUMAN TUMORS; MEMBRANE-BOUND; PATHOPHYSIOLOGICAL; TRANSMEMBRANES; TUMOR NECROSE FACTOR RECEPTOR FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTORS; TUMOR NECROSIS FACTORS;

ANTIBODIES;

HYBRID PROTEIN; MEMBRANE PROTEIN; REAGENT; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CHO CELL; FLOW CYTOMETRY; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION;

EID: 18744438211     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0029(20000801)50:3<243::AID-JEMT8>3.0.CO;2-B     Document Type: Article

References (37)

1. Agostini C, Zambello R, Trentin L, Cerutti A, Enthammer C, Facco M, Milani A, Sancetta R, Garbisa S, Semenzato G. 1995. Expression of TNF receptors by T cells and membrane TNF-alpha by alveolar macrophages suggests a role for TNF-alpha in the regulation of the local immune responses in the lung of HIV-1-infected patients. J Immunol 154:2928-2938.
2. Akassoglou K, Probert L, Kontogeorgos G, Kollias G. 1997. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 158:438-445.
3. Alexopoulou L, Pasparakis M, Kollias G. 1997. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur J Immunol 27: 2588-2592.
4. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729-733.
5. Browning JL, Androlewicz MJ, Ware CF. 1991. Lymphotoxin and an associated 33-kda glycoprotein are expressed on the surface of an activated human t cell hybridoma. J Immunol 147:1230-1237.
6. Crookston KP, Webb DJ, Wolf BB, Gonias SL. 1994. Classification of alpha 2-macroglobulin-cytokine interactions based on affinity of noncovalent association in solution under apparent equilibrium conditions. J Biol Chem 269:1533-1540.
7. Crowe PD, VanArsdale TL, Walter BN, Dahms KM, Ware CF. 1994. Production of lymphotoxin (LT alpha) and a soluble dimeric form of its receptor using the baculovirus expression system. J Immunol Methods 168:79-89.
8. Echtenacher B, Falk W, Männel DN, Krammer PH. 1990. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 145:3762-3766.
9. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. 1995. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21:190-198.
10. Georgopoulos S, Plows D, Kollias G. 1996. Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflamm 46:86-97.
11. Grell M. 1996. Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. J Inflamm 47: 8-17.
12. Grell M, Scheurich P. 1997. Tumor necrosis factor. In: LeRoith D, Bondy C, editors. Growth factors and cytokines in health and disease. Greenwich, CT: JAI Press, p 669-726.
13. Grell M, Douni E, Wajant H, Löhden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793-802.
14. Grell M, Zimmermann G, Gottfried E, Chen CM, Grünwald U, Huang DC, Wu Lee YH, Dürkop H, Engelmann H, Scheurich P, Wajant H, Strasser A. 1999. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 18:3034-3043.
15. Grewal IS, Flavell RA. 1998. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16:111-135.
16. Haas E, Grell M, Wajant H, Scheurich P. 1999. Continuous autotropic signaling by membrane-expressed tumor necrosis factor. J Biol Chem 274:18107-18112.
17. Hershkoviz R, Cahalon L, Miron S, Alon R, Sapir T, Akiyama SK, Yamada KM, Lider O. 1994. Tnf-alpha associated with fibronectin enhances phorbol myristate acetate-or antigen-mediated integrin-dependent adhesion of cd4+ t cells via protein tyrosine phosphorylation. J Immunol 153:554-65.
18. Hofsli E, Bakke O, Nonstad U, Espevik T. 1989. A flow cytometric and immunofluorescence microscopic study of tumor necrosis factor production and localization in human monocytes. Cell Immunol 122: 405-415.
19. Hsi ED, Remick DG. 1993. Rapid determination of cell-associated tumor necrosis factor production by flow cytometry. Lab Invest 68:740-745.
20. Kelsey SM, Allen PD, Razak K, Macey MG, Newland AC. 1993. Induction of surface tumor necrosis factor (TNF) expression and possible facilitation of surface TNF release from human monocytic cells by granulocyte-macrophage colony-stimulating factor or gamma interferon in combination with 1,25-dihydroxyvitamin D3. Exp Hematol 21:864-869.
21. Küsters S, Tiegs G, Alexopoulou L, Pasparakis M, Douni E, Künstle G, Bluethmann H, Wendel A, Pfizenmaier K, Kollias G, Grell M. 1997. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol 27:2870-2875.
22. Kwon B, Youn BS, Kwon BS. 1999. Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes. Curr Opin Immunol 11:340-345.
23. Lantz M, Thysell H, Nilsson E, Olsson I. 1991. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. J Clin Invest 88:2026-2031.
24. Luettig B, Decker T, Lohmann-Matthes ML. 1989. Evidence for the existence of two forms of membrane tumor necrosis factor: an integral protein and a molecule attached to its receptor. J Immunol 143:4034-4038.
25. Merlos-Suarez A, Fernandez-Larrea J, Reddy P, Baselga J, Arribas J. 1998. Pro-tumor necrosis factor-alpha processing activity is tightly controlled by a component that does not affect notch processing. J Biol Chem 273:24955-24962.
26. Moosmayer D, Wajant H, Gerlach E, Schmidt M, Brocks B, Pfizenmaier K. 1996. Characterization of different soluble TNF receptor (TNFR80) derivatives: positive influence of the intracellular domain on receptor/ligand interaction and TNF neutralization capacity. J Interferon Cytokine Res 16:471-477.
27. Moss ML, Jin SLC, Milla ME, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, Mccauley P, Mcgeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Warner J, Willard D, Becherer JD. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385:733-736.
28. Patel IR, Attur MG, Patel RN, Stuchin SA, Abagyan RA, Abramson SB, Amin AR. 1998. TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha. J Immunol 160:4570-4579.
29. Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M. 1990. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63:251-258.
30. Satoh M, Nakamura M, Saitoh H, Satoh H, Maesawa C, Segawa I, Tashiro A, Hiramori K. 1999. Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy. Circulation 99:3260-3265.
31. Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A, Tschopp J. 1998. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 187:1205-1213.
32. Sherblom AP, Decker JM, Muchmore AV. 1988. The lectin-like interaction between recombinant tumor necrosis factor and uromodulin. J Biol Chem 263:5418-5424.
33. Tanaka M, Itai T, Adachi M, Nagata S. 1998. Downregulation of Fas ligand by shedding. Nature Med 4:31-36.
34. Tang P, Hung MC, Klostergaard J. 1996. Human pro-tumor necrosis factor is a homotrimer. Biochemistry 35:8216-8225.
35. Vandenabeele P, Declercq W, Beyaert R, Fiers W. 1995. Two tumour necrosis factor receptors: Structure and function. Trends Cell Biol 5:329-399.
36. Vanderslice WE, Collins JL. 1991. Differences in the tumor necrosis factor-alpha-mediated lysis by fixed natural cytotoxic cells and fixed cytotoxic macrophages. J Immunol 146:156-161.
37. Weiss T, Grell M, Hessabi B, Bourteele S, Müller G, Scheurich P, Wajant H. 1997. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80-requirement of the TNF receptor-associated factor-2 binding site. J Immunol 158:2398-2404.